← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2009Last known activity
Aug 28, 2023
Timeline
2000s
- Jun 1, 2000
NovoCure Ltd.— Founded
Drugs by trial phase (26 distinct, 33 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Brain Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Colorectal Neoplasms
- Glioblastoma
- Glioma
- Gliosarcoma
- Lung Neoplasms
- Melanoma
- Meningioma
- Mesothelioma
- Neoplasm Metastasis
- Neoplasms
- Neoplastic Cells, Circulating
- Ovarian Neoplasms
- Pancreatic Neoplasms
Recent trials (33)
- NCT06390059Lead sponsorPhase 2Aug 28, 2023
- NCT05341349CollaboratorPhase 1Oct 13, 2022
- NCT05004025CollaboratorPhase 1Dec 31, 2021
- NCT04605913CollaboratorPhase 1/Phase 2Dec 31, 2020
- NCT04474353CollaboratorPhase 1Nov 30, 2020
- NCT04221503CollaboratorPhase 2Jan 31, 2020
- NCT04129515CollaboratorPhase 1/Phase 2Nov 30, 2019
- NCT03970252CollaboratorPhase 1/Phase 2Aug 1, 2019
- NCT03980249CollaboratorEarly Phase 1Jun 30, 2019
- NCT03903640CollaboratorPhase 2Jun 30, 2019
- NCT03705351CollaboratorPhase 1Apr 1, 2019
- NCT03940196Lead sponsorN/AMar 22, 2019
- NCT03606590Lead sponsorPhase 2Sep 30, 2018
- NCT03430791CollaboratorPhase 2Aug 31, 2018
- NCT03377491Lead sponsorPhase 3May 10, 2018
Details
- Founded
- Haifa, IL Jun 1, 2000
- Last known activity
- Aug 28, 2023